Generic drugs are usually associated with prescription (Rx) drugs; however, they are infiltrating the consumer health landscape via “branded generics” and private label across the world. Significant competitive pressures, along with an increasing need for affordable medicines, have caused manufacturers, distributors, marketers and retailers to rethink their strategies regarding generic drugs. Instead of a threat, they are slowly becoming an ally in a strategy to boost sales.
Euromonitor International’s Generic Drugs in consumer health global overview 2011 global briefing examines the size, growth trends and potential opportunities in the Consumer Health market. The strategic analyses include assessing the impacts of changing regulations, research breakthroughs and public health concerns on both the market and leading companies. Consumer attitudes towards the products and their personal healthcare needs are also explored.
Product coverage: Allergy Care, Child-Specific Consumer Health, Herbal/Traditional Products, OTC, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 30 years experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago and Sydney and a network of over 600 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.